Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence - Wikidata - wikimedia - TriplyDB

Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence

Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence

http://www.wikidata.org/entity/Q36950780

about

Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomes A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases Refining the Management of Rheumatoid Arthritis: the Benefits of Subcutaneous Tocilizumab Development of three-dimensional prints of arthritic joints for supporting patients' awareness to structural damage.Effectiveness of biologic DMARDs in monotherapy versus in combination with synthetic DMARDs in rheumatoid arthritis: data from the Swiss Clinical Quality Management Registry.Non-adherence to disease-modifying antirheumatic drugs is associated with higher disease activity in early arthritis patients in the first year of the disease Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study.Improving treatment adherence in patients with rheumatoid arthritis: what are the options?Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis.Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs.Agreement between Rheumatologist and Patient-reported Adherence to Methotrexate in a US Rheumatoid Arthritis Registry.Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis.Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study Therapeutic options after treatment failure in rheumatoid arthritis or spondyloarthritides.How to study determinants related to medication adherence in newly diagnosed polyarthritis patients for the development of a prediction instrument Use of medication reminders in patients with rheumatoid arthritis.Determinants of methotrexate adherence in rheumatoid arthritis patients.Influence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related).Impact of prior biologic use on persistence of treatment in patients with psoriatic arthritis enrolled in the US Corrona registry.Persistence With Conventional Triple Therapy Versus a Tumor Necrosis Factor Inhibitor and Methotrexate in US Veterans With Rheumatoid Arthritis.Predictors of patient decision to discontinue anti-rheumatic medication in patients with rheumatoid arthritis: results from the Ontario best practices research initiative.Improving medication adherence in rheumatoid arthritis (RA): a pilot study.Treatment adherence and disease burden of individuals with rheumatic diseases admitted as outpatients to a large rheumatology center in Shanghai, China.Concordance of Adherence Measurement Using Self-Reported Adherence Questionnaires and Medication Monitoring Devices: An Updated Review.Treatment adherence in systemic lupus erythematosus and rheumatoid arthritis: time to focus on this important issue: Treatment adherence in SLE and RA.Effect of long-term low dose prednisolone administration on bone mineral density: Relating to non-compliant women with rheumatoid arthritis.Support needs for medication use and the suitability of eHealth technologies to address these needs: a focus group study of older patients with rheumatoid arthritis.

P2860

Q26768683-2AA31612-C674-4E4F-8219-5101A17A5975 Q26778585-D14F8960-A4F6-4244-93F8-FA1F923E7D6E Q28080677-7873DC4C-4E9E-4991-97A8-B6861EE94794 Q30838247-383C4941-1621-462B-B762-FCCD38A8A906 Q30940329-8B84DDAB-DEC2-4F2E-B49D-9D16DDE7A868 Q36141017-2F1210CF-C757-449F-851C-F7F2C1FF9172 Q36202845-ED16BFE1-87EE-47BD-8631-7E4AF3A35C5B Q36784125-0D83F0FC-6A1C-4333-9A31-C5E5AAB1FC8B Q36887559-209A4575-0BD8-48EE-B507-9EF76227C816 Q36943002-F8557DF8-888E-4B62-9FE3-00469669F3F4 Q36963533-937D6604-48E2-4E05-A2F3-862956C377FF Q37337186-2CE6922C-FA74-4759-A839-9725499FE6BA Q37562617-EC685D87-9976-48D5-8A77-0B5C7F424EB8 Q38238931-D585A33A-568E-4F8E-8C34-7E077F7F1084 Q38263170-D48D2F51-D492-451B-83C8-4D7646002DB5 Q38405822-ECF39259-537A-4076-953E-F787AF9A051D Q38439965-D882CC5D-FED5-41CE-BD1C-A2814E5F5920 Q38867559-E43900D4-7F90-4D11-B713-3F72A2C48617 Q38921982-176751A7-6F50-4D44-A772-46BDA5703666 Q39702204-E918AAD7-54A7-4335-9E74-C7F01E4A0BC3 Q40503217-C1BF7E8E-91AB-49B3-AE74-C5A245E1F238 Q41213036-FB4A2806-2633-4A5D-88EF-7F57287586EE Q42731691-23474098-2EB6-4098-8089-749107FFB7AD Q47272447-9F51E12D-FC50-4D9D-B3F1-467D343B8AC2 Q50263999-24A6F769-E6D6-42FD-9A72-56F46926CA69 Q55092131-F2D0862A-B761-481C-82B6-626D2B481340 Q55260816-27F34FE4-82FC-4C1D-A044-EA4B0722C678

P2860

Electronic monitoring of oral therapies in ethnically diverse and economically disadvantaged patients with rheumatoid arthritis: consequences of low adherence

http://www.wikidata.org/entity/Q36950780

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Electronic monitoring of oral ...... consequences of low adherence

@en

type

label

Electronic monitoring of oral ...... consequences of low adherence

@en

prefLabel

Electronic monitoring of oral ...... consequences of low adherence

@en

P1433

Q36950780-0D77754D-260F-46B4-BEB4-29357F4B6B0D

P1476

Q36950780-D833287F-A292-4D6E-A64A-09034A922898

P2093

Q36950780-17F05AD7-04FE-40BD-9BAC-070C5CD0167D

Q36950780-6786A0EF-70E6-4AEB-9BCB-199A9B2FCAF2

Q36950780-6FFDE663-24B6-40A1-9729-DFE6C76CC342

Q36950780-94815236-126D-48B4-ADFD-6A4C080CD00C

Q36950780-95089084-851D-43DC-8962-144FA1791014

Q36950780-E9078CEF-8409-40F4-9675-4CB0C9EEF7A1

Q36950780-F1640024-AD36-4390-B730-0C525A4A2120

P2860

Q36950780-02A0E850-082E-4805-B8E6-A20CD3DC7A80

Q36950780-0BD8DB54-F5E1-481F-ACE8-49DB38DFE0D7

Q36950780-173C66DC-C902-4DE7-8891-8759206E3691

Q36950780-28FB85B2-B6CB-4681-844E-E1F8B1503552

Q36950780-2C3DB9F4-970A-4749-8AB0-16AAA66BBA9C

Q36950780-2DC82B4A-6D4C-4F7D-B338-7F68AF2B4DC8

Q36950780-3CB6717D-F5E4-40A4-AF80-45E953DA7517

Q36950780-423A7C51-C728-41E2-BABD-78861E571C5C

Q36950780-598B11F0-EE30-4F6D-B378-B31AF405438C

Q36950780-59C9DF8C-5F2F-4657-A83F-7BDB319F2463

P304

Q36950780-FCF0817D-56E0-491D-BCE2-969E5ACF2869

P31

Q36950780-0D60A9FC-2571-4622-8A2F-91F76242113E

P356

Q36950780-62ED7A14-1B5B-43C5-81C6-58D48B009098

P433

Q36950780-491A8427-E823-4AFA-AACA-5128C67750D7

P478

Q36950780-D659DA07-5A79-40F4-A22E-7BBD02338837

P50

Q36950780-D25C913D-A091-49D8-A46E-2E131EA05F94

P577

Q36950780-331CE7C8-BE81-4D8C-BC3D-C42F87F5F9C9

P5875

Q36950780-6DDFC792-7CCF-4248-9456-E1264932FE5E

P698

Q36950780-BC20D2EF-E252-40BB-8537-580451C47F53

P932

Q36950780-2BFE81C1-9692-4165-8B86-982BC8E2F4E2

P356

P1433

Arthritis & Rheumatology

P1476

Electronic monitoring of oral ...... consequences of low adherence

@en

P2093

Araceli Garcia-Gonzalez

http://www.w3.org/2001/XMLSchema#string

Christian A Waimann

http://www.w3.org/2001/XMLSchema#string

Maria E Suarez-Almazor

http://www.w3.org/2001/XMLSchema#string

Maria F Marengo

http://www.w3.org/2001/XMLSchema#string

Marsha N Richardson

http://www.w3.org/2001/XMLSchema#string

Sofia de Achaval

http://www.w3.org/2001/XMLSchema#string

Vanessa L Cox

http://www.w3.org/2001/XMLSchema#string

P2860

The MOS 36-ltem Short-Form Health Survey (SF-36)

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

How to read radiographs according to the Sharp/van der Heijde method.

Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus.

Influence of adherence to treatment and response of cholesterol on mortality in the coronary drug project.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Patient adherence to treatment: three decades of research. A comprehensive review.

Factors associated with attrition of African Americans during the recruitment phase of a clinical trial examining adherence among individuals with rheumatoid arthritis.

Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus

Assessment of adherence to and persistence on disease-modifying antirheumatic drugs (DMARDs) in patients with rheumatoid arthritis.

P304

1421-1429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/ART.37917

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P50

John D Reveille

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

237004912

http://www.w3.org/2001/XMLSchema#string

P698

23728826

http://www.w3.org/2001/XMLSchema#string

P932

3691007

http://www.w3.org/2001/XMLSchema#string